The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A single-blind, randomized, placebo-controlled phase II study to evaluate the impact of oral bisphosphonate treatment on bone mineral density in osteopenic women receiving adjuvant aromatase inhibitors: Interim analysis of “BONADIUV” trial.
Vieri Scotti
No relevant relationships to disclose
Icro Meattini
No relevant relationships to disclose
Sara Cecchini
No relevant relationships to disclose
Maria Laura De Feo
No relevant relationships to disclose
Calogero Saieva
No relevant relationships to disclose
Carla De Luca Cardillo
No relevant relationships to disclose
Lorenzo Livi
No relevant relationships to disclose